Do you want to read an article? Please log in or register.
Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy
Ocular Oncology
Related content
Macular DiseasesOcular OncologyRetinal Diseases
Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients
Br J Ophthalmol.
Dalvin LA, Zhang Q, Hamershock RA, Chang M, Yu MD, Mashayekhi A, Shields CL
doi: 10.1136/bjophthalmol-2019-314686.
Ocular Oncology
Impact of uveal melanoma thickness on post-plaque radiotherapy outcomes in the prophylactic anti-vascular endothelial growth factor era in 1131 patients
Clin Exp Ophthalmol.
Yang X, Dalvin LA, Mazloumi M, Chang M, Shields JA, Mashayekhi A, Shields CL
doi: 10.1111/ceo.13758.
COMMENTED
Ocular Oncology
Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1001/jamaophthalmol.2019.5132.
RECOMMENDED
Ocular Oncology
Photodynamic Therapy for Choroidal Metastasis Tumor Control and Visual Outcomes in 58 Cases: The 2019 Burnier International Ocular Pathology Society Lecture
★ 2
Recommended by
Prof. Dr Daniel Barthelmes, Faculty Member
Ophthalmol Retina.
Shields CL, Khoo CTL, Mazloumi M, Mashayekhi A, Shields JA
doi: 10.1016/j.oret.2019.10.009.
Ocular Oncology
THE SMALL FATAL CHOROIDAL MELANOMA STUDY A Survey by the European Ophthalmic Oncology Group
Am J Ophthalmol.
Jouhi S, Jager MJ, de Geus SJR, Desjardins L, Eide NA, Grange JD, Kiilgaard JF, Seregard S, Midena E, Parrozzani R, Caujolle JP, Rospond-Kubiak I, Kivelä TT
doi: 10.1016/j.ajo.2019.01.031.
Macular Diseases
Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration: data from the INSIGHT study using the Swedish Macula Register
Acta Ophthalmol.
Lövestam Adrian M, Vassilev ZP, Westborg I
doi: 10.1111/aos.13864.
Ocular Oncology
Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D
Ophthalmology.
Vichitvejpaisal P, Dalvin LA, Mazloumi M, Ewens KG, Ganguly A, Shields CL
doi: 10.1016/j.ophtha.2019.04.027.
Ocular Oncology
Fractionated stereotactic radiotherapy for uveal melanoma: Long-term outcome and control rates
Acta Ophthalmol
van Beek JGM, van Rij CM, Baart SJ, Yavuzyigitoglu S, Bergmann MJ, Paridaens D, Naus NC, Kiliç E
doi: 10.1111/aos.15029
Further Publications
Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related choroidal Neovascularisation (IVAN) Trial
Ophthalmology.
Evans RN, Reeves BC, Phillips D, Muldrew KA, Rogers C, Harding SP, Chakravarthy U, IVAN Study Group.
doi: 10.1016/j.ophtha.2020.03.020.